CBIO · Forms 3, 4, 5
Insider trades at CRESCENT BIOPHARMA, INC.
7 insiders sold $286K of CRESCENT BIOPHARMA, INC. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for CRESCENT BIOPHARMA, INC. (CBIO) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Joshua T Brumm | Chief Executive Officer | Sell | 7,837 | $16.71 | $131K | Form 4 | |
| Jonathan McNeill | President and COO | Sell | 3,839 | $16.71 | $64K | Form 4 | |
| Ryan Lynch | See Remarks | Sell | 240 | $17.90 | $4K | Form 4 | |
| Jan Pinkas | Chief Scientific Officer | Sell | 658 | $17.90 | $12K | Form 4 | |
| Ellie Eunkyung Im | Chief Medical Officer | Sell | 623 | $17.90 | $11K | Form 4 | |
| Richard William Scalzo | Chief Financial Officer | Sell | 568 | $17.90 | $10K | Form 4 | |
| Barbara Harlin Bispham | See Remarks | Sell | 620 | $17.90 | $11K | Form 4 | |
| Joshua T Brumm | Chief Executive Officer | Sell | 1,610 | $17.90 | $29K | Form 4 | |
| Jonathan McNeill | President and COO | Sell | 731 | $17.90 | $13K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.